$15 million boost to research funding
T-cell research in the Department of Microbiology and Immunology at forefront in latest NHMRC funding round.
Congratulations to our researchers in the School of Biomedical Sciences who have secured NHMRC 2021 Investigator Grants.
Investigator Grants focus on innovative and creative research, supporting different career stages and allowing flexibility for researchers to follow new research directions as they arise and to form collaborations as needed.
The University of Melbourne received over $80m in Investigator Grant funding, with the NHMRC approving 254 projects from the University, from a total of 1,722 applications.
12 applications from across the School of Biomedical Sciences were successful with research focused on T cells, respiratory viruses and vaccines.
Engineering T cells to promote peripheral immunity | |
Generating An Effective T-Cell Based Influenza Vaccine | |
Harnessing immunity for optimal SARS-CoV-2 and influenza vaccines | |
Serological Correlates of Protection and Pathogenesis in Infectious and Autoimmune Disease | |
Understanding how DC-T cell interactions regulate human disease | |
Immunity mediated by MHC class I-related protein (MR1) | |
Unconventional T cells: Fundamental biology and therapeutic potential | |
Harnessing T cell immunity to boost vaccine efficacy | |
Harnessing CD4+ Regulatory T Cells to Enhance Formation of Protective Immunity Against Human Viruses | |
Driving rational improvement of vaccines against respiratory viruses | |
Targeting skeletal muscle for the treatment of insulin resistance | |
Developing a multi-omics platform for the diagnosis of mitochondrial disease |